GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Nap1l1 | affects expression | ISO | Nap1l1 (Mus musculus) | 6480464 | CTD | Valproic Acid affects the expression of NAP1L1 mRNA | PMID:17292431 | Nap1l1 | affects expression | ISO | NAP1L1 (Homo sapiens) | 6480464 | CTD | Valproic Acid affects the expression of NAP1L1 mRNA | PMID:25979313 | Nap1l1 | decreases expression | ISO | Nap1l1 (Mus musculus) | 6480464 | CTD | Valproic Acid results in decreased expression of NAP1L1 mRNA | PMID:19136453 | Nap1l1 | decreases expression | ISO | NAP1L1 (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of NAP1L1 mRNA | PMID:23179753 PMID:27188386 PMID:28001369 | Nap1l1 | multiple interactions | ISO | NAP1L1 (Homo sapiens) | 6480464 | CTD | [Hydralazine co-treated with Valproic Acid] results in increased expression of NAP1L1 mRNA | PMID:17183730 | |
Go Back to source page | Continue to Ontology report |